Renee Gaeta - 17 Aug 2026 Form 4 Insider Report for Outset Medical, Inc. (OM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Aug 2026, 18:46:00 UTC
Prior SEC filing
29 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John Brottem For: Renee Gaeta

Key filing fact

Renee Gaeta filed Form 4 for Outset Medical, Inc. (OM) on 18 Aug 2026.

Key facts

  • This page summarizes Renee Gaeta's Form 4 filing for Outset Medical, Inc. (OM).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Aug 2026, 18:46.

Change

  • Previous filing in this sequence was filed on 29 Jun 2026.
  • Current net transaction value: -$19,944.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001742428 Primary reporting owner

Gaeta Renee

Relationship
Chief Financial Officer
Address
3052 ORCHARD DRIVE, SAN JOSE
Signature
John Brottem For: Renee Gaeta
Signature date
18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OM transaction

Common Stock

Sale

Transaction value
$19,944
Shares
-4,543
Change %
-2.5%
Price
$4.39
Shares after
180,840
Date
17 Aug 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 12,322 shares of Common Stock underlying RSUs granted to the reporting person on June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .